Convergent Therapeutics
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $29M
Investors
- 3
About Convergent Therapeutics
Founded in 2021 and based in Massachusetts, US, Convergent Therapeutics, Inc. is a company that focuses on developing solutions for treating cancer. Philip Kantoff (CEO/CMO) and Neil Bander are the co-founders of the company. In September 2024, Convergent Therapeutics, Inc. The company's product candidate is CONV01-a, a radioantibody that is specifically directed against PSMA, an antigen that is expressed on the surface of almost all prostate cancer cells. Treatment techniques like chemotherapy, hormone therapy, surgery, targeted therapy, radiation therapy, and immunotherapy can all benefit from CONV01-a. The firm leverages radioantibody technology to target and destroy cancer cells with the least amount of harm to healthy tissues. To create radioantibodies, Convergent Therapeutics' patented antibodies are combined with radionuclides like actinium-225 (225Ac). These radioantibodies attach to receptors on the surface of cancer cells and are then taken up by the tumor cells internally. After entering, they carry their radioactive payload directly to the cell's nucleus, where it causes permanent DNA damage and cell death.
Who invested in Convergent Therapeutics
3 investors across 1 round
See all investors in Convergent Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 27, 2023
Amount
$29M
Investors
Questions about Convergent Therapeutics
Who invested in Convergent Therapeutics?
Convergent Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Convergent Therapeutics raised?
Convergent Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Convergent Therapeutics last raise money?
Convergent Therapeutics's most recent round on record is a Series A, in Apr 2023.
What does Convergent Therapeutics do?
Founded in 2021 and based in Massachusetts, US, Convergent Therapeutics, Inc.
Where is Convergent Therapeutics headquartered?
Convergent Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Convergent Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Convergent Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Convergent Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.